BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems Recall
BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems
FDA recall Class II
Ongoing
FDA lists this Class II recall for BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1877-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Apr 30, 2025
- FDA report date
- Jun 4, 2025
- Quantity in commerce
- 30 kits
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems
Affected model & UDI checker
Search the exact identifiers published for Z-1877-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 423740 | BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems | Check source notice | Not specified |
FDA code information
Lot# 1475424/ UDI: None
Why was this product recalled?
Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Biofire Diagnostics, LLC take?
On April 30, 2025, Biomerieux issued a "Urgent Field Safety Notice" to affected consignees via email. Biomerieux asked consignees to take the following actions: 1. Immediately examine your inventory for the lot identified in this field safety notice. 2. Discontinue use and discard any remaining product from this lot in your possession. 3. As previously confirmed discontinued use of product, please confirm the amount of kits destroyed on the attached Acknowledgement of Receipt Form. 4. If you have further distributed this product, please identify any recipients and notify them at once. 5. Please complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1877-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology